References
- Heininger U, Seward JF. Varicella. Lancet 2006; 368: 1365-76.
- Gershon AA, Takahashi M, Seward JF. Varicella vaccine. In: Plotkin S, Orenstein W, editors. Vaccines (4th ed.). Philadelphia: WB Saunders, 2004: 783-823.
- Takahashi M, Okuno Y, Otsuka T, Osame J, Takamizawa A. Development of a live attenuated varicella vaccine. Biken J 1975; 18: 25-33.
- Wutzler P, Knuf M, Liese J. Varicella: efficacy of two-dose vaccination in childhood. Dtsch Arztebl Int 2008; 105: 567-72.
- World Health Organzation: The WHO position paper on varicella vaccines. Wkly Epidemiol Rec 1998; 73: 241-8.
- Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V. et al. Varicella vaccination in Europe - taking the practical approach. BMC Med 2009; 7: 26.
- Ministrstvo za zdravje RS. Program cepljenja in zaščite z zdravili za leto 2011. Pridobljeno 15.3.2012 s spletne strani: http://www.mz.gov.si/fileadmin/mz.gov.si/pageuploads/pravilniki/2011_objavljeni_v_UL/program_cepljenja_2011_okt_2011.pdf
- Grose C. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005. J Clin Virol 2005; 33: 89-98.
- American Academy of Pediatrics Committee on Infectious Diseases. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunzation schedule. Pediatrics 2007; 120: 221-31.
- Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT. et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics 2006; 117: 1070-7.
- Seward JF, Marin M, Vázquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis 2008; 197 (Suppl 2): 82-9.
- Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 2008; 122: 744-51.
- Bayer O, Heininger U, Heiligensetzer C, von Kries R. Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine 2007; 25: 6655-60.
- Höhle M, Siedler A, Bader HM, Ludwig M, Heininger U, von Kries R. Assessment of varicella vaccine effectiveness in Germany: a time-series approach. Epidemiol Infect 2010: 1-10.
- Centers for Disease Control and Prevention. Prevention of Varicella Recommendations of the Advisory Committee on Immunzation Practices (ACIP). MMWR 2007; 56: 1-48.
- Wiese-Posselt M, Hellenbrand W. Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation. Euro Surveill 2010; 15: 19548.
- Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B. et al. Study Group for Varivax. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 2004; 23: 132-7.
- Shapiro ED, Vazquez M, Esposito D, Holabird N, Steinberg SP, Dziura J. et al. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis 2011; 203: 312-5.
- Gould PL, Leung J, Scott C, Schmid DS, Deng H, Lopez A. et al. An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients-Arkansas, 2006. Pediatr Infect Dis J 2009; 28: 678-81.
- Nguyen MD, Perella D, Watson B, Marin M, Renwick M, Spain CV. Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, Pennsylvania, 2006. Pediatr Infect Dis J 2010; 29: 685-9.
- Spackova M, Wiese-Posselt M, Dehnert M, Matysiak-Klose D, Heininger U, Siedler A. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine 2010; 28: 686-91.
- Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine 2010; 28: 3385-97.
- Gao Z, Gidding HF, Wood JG, MacIntyre CR. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiol Infect 2010; 138: 457-68.
- Fine PE, Zell ER. Outbreaks in highly vaccinated populations: implications for studies of vaccine performance. Am J Epidemiol 1994; 139: 77-90.
- Louz D, Bergmans HE, Loos BP, Hoeben RC. Emergence of viral diseases: mathematical modeling as a tool for infection control, policy and decision making. Crit Rev Microbiol 2010; 36: 195-211.
- Temime L, Hejblum G, Setbon M, Valleron AJ. The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study. Epidemiol Infect 2008; 136: 289-98.
- Levin SA, Grenfell B, Hastings A, Perelson AS. Mathematical and computational challenges in population biology and ecosystems science. Science 1997; 275: 334-43.
- Arvin A, Gershon A: Control of varicella: why is a two-dose schedule necessary? Pediatr Infect Dis J 2006; 25: 475-6.
- Li S, Chan IS, Matthews H et al.: Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection. Pediatr Infect Dis J 2002; 21: 337-42.
- Chaves SS, Gargiullo P, Zhang JX, Civen R, Guris D, Mascola L, Seward JF. Loss of vaccine-induced immunity to varicella over time. N Engl J Med 2007; 356: 1121-9.
- Shinefield H, Black S, Digilio L, Reisinger K, Blatter M, Gress JO. et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J 2005; 24: 665-9.